Who was studied, and how
Four numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 21 other studies
The trial randomly assignedassigned by chance
Lowered first coprimary outcome−29%
Lowered second coprimary outcome−28%
Reported lower the LDL cholesterol level, no range given−33.7
randomisedthe abstract, start to end
… in the LDL cholesterol level was 33.7 mg per deciliter (0.87 mmol per liter) greater in the combined-therapy group than in the dual-placebo group, and the decrease in systolic blood pressure was 6.2 mm Hg greater with combined …
… in the dual-placebo group (hazard ratio, 0.71; 95% confidence interval [CI], …
… (5.9%), respectively (hazard ratio, 0.72; 95% CI, 0.57 to 0.89; …
Antihypertensives × cardiovascular eventshelps?one trial
Statins × cardiovascular eventshelps?replicated